Can ELISPOT be applied to a clinical setting as a diagnostic utility for neuroborreliosis?

Cells

Volumn 1, Issue 2, 2012, Pages 153-167

  Nordberg, Marika ^a,b   Forsberg, Pia ^a,c   Nyman, Dag ^b   Skogman, Barbro H ^d   Nyberg, Clara ^b   Ernerudh, Jan ^a,c   Eliasson, Ingvar ^e   Ekerfelt, Christina ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b The Åland Borrelia Group   (Finland)

^c Department of Clinical Immunology and Transfusion Medicine   (Sweden)

^d Dalarna   (Sweden)

^e NAL Medical Centre Hospital   (Sweden)

Author keywords

Borrelia burgdorferi; Cerebrospinal fluid; Diagnostic test; ELISPOT; Neuroborreliosis; Sensitivity; Specificity

Indexed keywords

AMOXICILLIN; CEFTRIAXONE; DOXYCYCLINE; GAMMA INTERFERON;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD BRAIN BARRIER; BORRELIA BURGDORFERI; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HYPOTHYROIDISM; LYME DISEASE; MALE; PLEOCYTOSIS; PRESCHOOL CHILD; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TICK BORNE ENCEPHALITIS;

EID: 84893606893     PISSN: None     EISSN: 20734409     Source Type: Journal    
DOI: 10.3390/cells1020153     Document Type: Article

References (53)

1. Stanek, G.; Fingerle, V.; Hunfeld, K.P.; Jaulhac, B.; Kaiser, R.; Krause, A.; Kristoferitsch, W.; O'Connell, S.; Ornstein, K.; Strle, F.; et al. Lyme borreliosis: Clinical case definitions for diagnosis and management in europe. Clin. Microbiol. Infect. 2011, 17, 697-699.
2. Stanek, G.; Strle, F. Lyme borreliosis. Lancet 2003, 362, 1639-1647.
3. Mygland, A.; Ljostad, U.; Fingerle, V.; Rupprecht, T.; Schmutzhard, E.; Steiner, I. Efns guidelines on the diagnosis and management of european lyme neuroborreliosis. Eur. J. Neurol. 2010, 17, e11-e14.
4. Ljostad, U.; Skarpaas, T.; Mygland, A. Clinical usefulness of intrathecal antibody testing in acute lyme neuroborreliosis. Eur. J. Neurol. 2007, 14, 873-876.
5. Wilske, B. Epidemiology and diagnosis of lyme borreliosis. Ann. Med. 2005, 37, 568-579.
6. Brouqui, P.; Bacellar, F.; Baranton, G.; Birtles, R.J.; Bjoersdorff, A.; Blanco, J.R.; Caruso, G.; Cinco, M.; Fournier, P.E.; Francavilla, E.; et al. Guidelines for the diagnosis of tick-borne bacterial diseases in europe. Clin. Microbiol. Infect. 2004, 10, 1108-1132.
7. Aguero-Rosenfeld, M.E.; Wang, G.; Schwartz, I.; Wormser, G.P. Diagnosis of lyme borreliosis. Clin. Microbiol. Rev. 2005, 18, 484-509.
8. Hammers-Berggren, S.; Hansen, K.; Lebech, A.M.; Karlsson, M. Borrelia burgdorferi-specific intrathecal antibody production in neuroborreliosis: A follow-up study. Neurology 1993, 43, 169-175.
9. Kruger, H.; Reuss, K.; Pulz, M.; Rohrbach, E.; Pflughaupt, K.W.; Martin, R.; Mertens, H.G. Meningoradiculitis and encephalomyelitis due to borrelia burgdorferi: A follow-up study of 72 patients over 27 years. J. Neurol. 1989, 236, 322-328.
10. Cerar, T.; Ogrinc, K.; Strle, F.; Ruzic-Sabljic, E. Humoral immune responses in patients with lyme neuroborreliosis. Clin. Vaccine Immunol. 2010, 17, 645-650.
11. Coyle, P.K.; Schutzer, S.E.; Deng, Z.; Krupp, L.B.; Belman, A.L.; Benach, J.L.; Luft, B.J. Detection of borrelia burgdorferi-specific antigen in antibody-negative cerebrospinal fluid in neurologic lyme disease. Neurology 1995, 45, 2010-2015.
12. Lawrence, C.; Lipton, R.B.; Lowy, F.D.; Coyle, P.K. Seronegative chronic relapsing neuroborreliosis. Eur. Neurol. 1995, 35, 113-117.
13. Oksi, J.; Uksila, J.; Marjamaki, M.; Nikoskelainen, J.; Viljanen, M.K. Antibodies against whole sonicated borrelia burgdorferi spirochetes, 41-kilodalton flagellin, and p39 protein in patients with pcr-or culture-proven late lyme borreliosis. J. Clin. Microbiol. 1995, 33, 2260-2264.
14. Schutzer, S.E.; Coyle, P.K.; Belman, A.L.; Golightly, M.G.; Drulle, J. Sequestration of antibody to borrelia burgdorferi in immune complexes in seronegative lyme disease. Lancet 1990, 335, 312-315.
15. Dattwyler, R.J.; Volkman, D.J.; Luft, B.J.; Halperin, J.J.; Thomas, J.; Golightly, M.G. Seronegative lyme disease. Dissociation of specific t-and b-lymphocyte responses to borrelia burgdorferi. New Engl. J. Med. 1988, 319, 1441-1446.
16. Wilske, B.; Fingerle, V.; Schulte-Spechtel, U. Microbiological and serological diagnosis of lyme borreliosis. FEMS Immunol. Med. Microbiol. 2007, 49, 13-21.
17. Seriburi, V.; Ndukwe, N.; Chang, Z.; Cox, M.E.; Wormser, G.P. High frequency of false positive igm immunoblots for borrelia burgdorferi in clinical practic. Clin. Microbiol. Infect. 2011, doi: 10.1111/j.1469-0691.2011.03749.x.
18. Wormser, G.P.; Dattwyler, R.J.; Shapiro, E.D.; Halperin, J.J.; Steere, A.C.; Klempner, M.S.; Krause, P.J.; Bakken, J.S.; Strle, F.; Stanek, G.; et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: Clinical practice guidelines by the infectious diseases society of america. Clin. Infect. Dis. 2006, 43, 1089-1134.
19. Wilske, B. Diagnosis of lyme borreliosis in europe. Vector Borne Zoonotic Dis. 2003, 3, 215-227.
20. Blanc, F.; Jaulhac, B.; Fleury, M.; de Seze, J.; de Martino, S.J.; Remy, V.; Blaison, G.; Hansmann, Y.; Christmann, D.; Tranchant, C. Relevance of the antibody index to diagnose lyme neuroborreliosis among seropositive patients. Neurology 2007, 69, 953-958.
21. Hansen, K.; Cruz, M.; Link, H. Oligoclonal borrelia burgdorferi-specific igg antibodies in cerebrospinal fluid in lyme neuroborreliosis. J. Infect. Dis. 1990, 161, 1194-1202.
22. Steere, A.C.; Berardi, V.P.; Weeks, K.E.; Logigian, E.L.; Ackermann, R. Evaluation of the intrathecal antibody response to borrelia burgdorferi as a diagnostic test for lyme neuroborreliosis. J. Infect. Dis. 1990, 161, 1203-1209.
23. Stiernstedt, G.T.; Granstrom, M.; Hederstedt, B.; Skoldenberg, B. Diagnosis of spirochetal meningitis by enzyme-linked immunosorbent assay and indirect immunofluorescence assay in serum and cerebrospinal fluid. J. Clin. Microbiol. 1985, 21, 819-825.
24. Picha, D.; Moravcova, L.; Zdarsky, E.; Benes, J. Clinical comparison of immunoblot and antibody index for detection of intrathecal synthesis of specific antibodies in lyme neuroborreliosis. Eur. J. Clin. Microbiol. Infect. Dis. 2000, 19, 805-806.
25. Tumani, H.; Nolker, G.; Reiber, H. Relevance of cerebrospinal fluid variables for early diagnosis of neuroborreliosis. Neurology 1995, 45, 1663-1670.
26. Aguero-Rosenfeld, M.E. Lyme disease: Laboratory issues. Infect. Dis. Clin. North Am. 2008, 22, 301-313.
27. Tjernberg, I.; Kruger, G.; Eliasson, I. C6 peptide elisa test in the serodiagnosis of lyme borreliosis in sweden. Eur. J. Clin. Microbiol. Infect. Dis. 2007, 26, 37-42.
28. Dressler, F.; Yoshinari, N.H.; Steere, A.C. The t-cell proliferative assay in the diagnosis of lyme disease. Ann. Intern. Med. 1991, 115, 533-539.
29. Ekerfelt, C.; Ernerudh, J.; Forsberg, P.; Bergström, S. Augmented intrathecal secretion of interferon-γ in response to borrelia garinii in neuroborreliosis. J. Neuroimmunol. 1998, 89, 177-181.
30. Forsberg, P.; Ernerudh, J.; Ekerfelt, C.; Roberg, M.; Vrethem, M.; Bergstrom, S. The outer surface proteins of lyme disease borrelia spirochetes stimulate t cells to secrete interferon-gamma (ifn-gamma): Diagnostic and pathogenic implications. Clin. Exp. Immunol. 1995, 101, 453-460.
31. Oksi, J.; Savolainen, J.; Pène, J.; Bòusquet, J.; Laippala, P.; Viljanen, M.K. Decreased interleukin-4 and increased gamma interferon production by peripheral blood mononuclear cells of patients with lyme borreliosis. Infect. Immun. 1996, 64, 3620-3623.
32. Widhe, M.; Ekerfelt, C.; Forsberg, P.; Bergström, S.; Ernerudh, J. Igg subclasses in lyme borreliosis: A study of specific igg subclass distribution in an IFN-γ predominated disease. Scand. J. Immunol. 1998, 47, 575-581.
33. Widhe, M.; Jarefors, S.; Ekerfelt, C.; Vrethem, M.; Bergström, S.; Forsberg, P.; Ernerudh, J. Borrelia specific ifn-g and il-4 secretion in blood and csf during the course of human lyme borreliosis: Relation to clinical outcome. J. Infect. Dis. 2004, 189, 1881-1891.
34. Yin, Z.; Braun, J.; Neure, L.; Wu, P.; Eggens, U.; Krause, A.; Kamradt, T.; Sieper, J. T cell cytokine pattern in the joints of patients with lyme arthritis and its regulation by cytokines and anticytokines. Arthritis Rheum. 1997, 40, 69-79.
35. Ekerfelt, C.; Ernerudh, J.; Bunikis, J.; Vrethem, M.; Aagesen, J.; Roberg, M.; Bergstrom, S.; Forsberg, P. Compartmentalization of antigen specific cytokine responses to the central nervous system in cns borreliosis: Secretion of ifn-gamma predominates over il-4 secretion in response to outer surface proteins of lyme disease borrelia spirochetes. J. Neuroimmunol. 1997, 79, 155-162.
36. Granström, M. Borrelios/lyme disease-Serologi/diagnostik. Inf. från Läkemedelsverket 1998, 9, 98.
37. Gross, D.M.; Steere, A.C.; Huber, B.T. T helper 1 response is dominant and localized to the synovial fluid in patients with lyme arthritis. J. Immunol. 1998, 160, 1022-1028.
38. Grusell, M.; Widhe, M.; Ekerfelt, C. Increased expression of the th1-inducing cytokines interleukin-12 and interleukin-18 in cerebrospinal fluid but not in sera from patients with lyme neuroborreliosis. J. Neuroimmunol. 2002, 131, 173-178.
39. Wang, W.-Z.; Fredriksson, S.; Sun, J.-B.; Link, H. Lyme neuroborreliosis: Evidence for persistent up-regulation of borrelia burgdorferi-reactive cells secreting interferon-γ. Scand. J. Immunol. 1995, 42, 694-700.
40. Lange, C.; Mori, T. Advances in the diagnosis of tuberculosis. Respirology 2010, 15, 220-240.
41. Diel, R.; Goletti, D.; Ferrara, G.; Bothamley, G.; Cirillo, D.; Kampmann, B.; Lange, C.; Losi, M.; Markova, R.; Migliori, G.B.; et al. Interferon-gamma release assays for the diagnosis of latent mycobacterium tuberculosis infection: A systematic review and meta-analysis. Eur. Respir. J. 2011, 37, 88-99.
42. Finland's National institute for health and welfare, R.o.D., Statistical Database. Available online: http://www3.ktl.fi/stat/ (accessed on 9 May 2012).
43. Widhe, M.; Skogman, B.H.; Jarefors, S.; Eknefelt, M.; Enestrom, G.; Nordwall, M.; Ekerfelt, C.; Croner, S.; Bergstrom, S.; Forsberg, P.; et al. Up-regulation of borrelia-specific il-4-and ifn-gamma-secreting cells in cerebrospinal fluid from children with lyme neuroborreliosis. Int. Immunol. 2005, 17, 1283-1291.
44. Ekerfelt, C.; Masreliez, C.; Svenvik, M.; Ernerudh, J.; Roberg, M.; Forsberg, P. Antibodies and t-cell reactivity to borrelia burgdorferi in an asymptomatic population: A study of healthy blood donors in an inland town district in the south-east of sweden. Scand. J. Infect. Dis. 2001, 33, 806-808.
45. Berglund, J.; Eitrem, R.; Ornstein, K.; Lindberg, A.; Ringer, A.; Elmrud, H.; Carlsson, M.; Runehagen, A.; Svanborg, C.; Norrby, R. An epidemiologic study of lyme disease in southern sweden. New Engl. J. Med. 1995, 333, 1319-1327.
46. Kalish, R.A.; McHugh, G.; Granquist, J.; Shea, B.; Ruthazer, R.; Steere, A.C. Persistence of immunoglobulin m or immunoglobulin g antibody responses to borrelia burgdorferi 10-20 years after active lyme disease. Clin. Infect. Dis. 2001, 33, 780-785.
47. Bergstrom, S.; Sjostedt, A.; Dotevall, L.; Kaijser, B.; Ekstrand-Hammarstrom, B.; Wallberg, C.; Skogman, G.; Barbour, A.G. Diagnosis of lyme borreliosis by an enzyme immunoassay detecting immunoglobulin g reactive to purified borrelia burgdorferi cell components. Eur. J. Clin. Microbiol. Infect. Dis. 1991, 10, 422-427.
48. Ekerfelt, C.; Ernerudh, J.; Forsberg, P.; Bergstrom, S. Augmented intrathecal secretion of interferon-gamma in response to borrelia garinii in neuroborreliosis. J. Neuroimmunol. 1998, 89, 177-181.
49. Widhe, M.; Jarefors, S.; Ekerfelt, C.; Vrethem, M.; Bergstrom, S.; Forsberg, P.; Ernerudh, J. Borrelia-specific interferon-gamma and interleukin-4 secretion in cerebrospinal fluid and blood during lyme borreliosis in humans: Association with clinical outcome. J. Infect. Dis. 2004, 189, 1881-1891.
50. Widhe, M.; Ekerfelt, C.; Jarefors, S.; Skogman, B.H.; Peterson, E.M.; Bergstrom, S.; Forsberg, P.; Ernerudh, J. T-cell epitope mapping of the borrelia garinii outer surface protein a in lyme neuroborreliosis. Scand. J. Immunol. 2009, 70, 141-148.
51. Reiber, H. Flow rate of cerebrospinal fluid (csf)-A concept common to normal blood-csf barrier function and to dysfunction in neurological diseases. J. Neurol. Sci. 1994, 122, 189-203.
52. Nyman, D.; Wahlberg, P.; Carlsson, S.-A.; Granlund, H.; Jansson, C.; Johansson, C.; Nyberg, C. Lyme borreliosis-praktiska riktlinjer för diagnos och behandling. Finl. Läkartidning 2006, 61, 3219.
53. Griner, P.F.; Mayewski, R.J.; Mushlin, A.I.; Greenland, P. Selection and interpretation of diagnostic tests and procedures. Principles and applications. Ann. Intern. Med. 1981, 94, 557-592.